Despite decades of regulatory guidance, expanded access to data, and repeated public postmortems of failed programs, … Common Clinical Trial Mistakes Pharma Companies Keep RepeatingRead more
Pharmaceutical R&D
How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market
In the United States, drug approval timelines are becoming harder to predict. Despite record investment in … How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical MarketRead more